Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Inicio Explorar nav.journalClub Tendencias

⌘+K

Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice | Synapse

March 14, 2019Journal of Neuroinflammation259 citationsOpen Access

Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice

ZGZhuo GongSun Yat-sen University JHJingyi HuangJilin University BXBiao XuLanzhou Veterinary Research Institute

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our results indicated that UA imparted cognitive protection by protecting neurons from death and triggering neurogenesis via anti-inflammatory signaling in APP/PS1 mice, suggesting that UA might be a promising therapeutic drug to treat AD.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Gong et al. (2019) studied this question.

synapsesocial.com/papers/69dbdbcb5b363cdf1c8360e6 https://doi.org/10.1186/s12974-019-1450-3

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease1994 · 1,263 citations
2Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration2001 · 166 citations
3Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders2013 · 987 citations
4Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer’s mice2015 · 28 citations
5Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease2018 · 90 citations